Fapon Showcases Local Manufacturing Solutions at MEDICA 2026 in Düsseldorf

Fapon's Role at MEDICA 2026



Fapon, a leading global organization in life sciences, is set to exhibit its innovative solutions at the prestigious MEDICA 2026 event, taking place from November 16 to 19 in Düsseldorf, Germany. At this international trade fair, Fapon aims to showcase its cutting-edge manufacturing solutions and its extensive product range in in vitro diagnostics (IVD).

Fapon is leveraging its technological expertise to assist IVD manufacturers worldwide by offering comprehensive technology transfer and integrated diagnostic solutions. The organization aims to enhance local manufacturing capabilities and meet the evolving demands of regional markets. This commitment to supporting local production is particularly significant in today's healthcare landscape, where rapid access to reliable diagnostic tools is crucial.

Local Manufacturing Solutions



At the MEDICA fair, Fapon will highlight its local manufacturing solutions that encompass various diagnostic modalities, including chemiluminescence immunoassays (CLIA), ELISA, clinical biochemistry, point-of-care testing (POCT), and molecular diagnostics (MDx). By incorporating flexible collaboration models, Fapon provides extensive technology transfer support, essential raw materials, bulk reagents, and assistance with product registration. This holistic approach empowers partners to either establish or expand their local IVD manufacturing capabilities effectively.

Fapon’s assistance spans the entire development process, from assay development through to production and local market commercialization. The organization is also introducing its comprehensive IVD solutions, which combine critical raw materials, custom reagent services, and open-system instruments. Their capabilities include antibody discovery, process development, reagent formulation, and customization, providing significant support to diagnostic manufacturers throughout various stages of product development.

One notable innovation is Fapon's blood analysis solution targeting Alzheimer's disease (AD). This offering includes essential raw materials and bulk reagents for key biomarkers, such as p-tau 217, p-tau 181, Aβ40, Aβ42, GFAP, and NfL, aiding in the development of blood-based diagnostics for AD. This comprehensive suite of integrated capabilities ensures adaptable technical and product support for partners looking to refine or expand their diagnostic portfolios.

Recombinant Quality Control Materials



Another critical aspect of Fapon's offerings includes recombinant quality control (QC) materials developed for consistent assay performance. Utilizing recombinant expression technology, these materials are designed to mitigate supply variability and associated biosafety risks linked to naturally sourced raw materials. The approach guarantees high consistency across production batches, which is vital for maintaining quality standards in diagnostic testing.

Fapon’s production capabilities are robust, providing scalable solutions with batch sizes tailored to client demands. Production can be conducted in volumes of 0.8 L, 2 L, 6 L, or 60 L, utilizing containers of up to 200 L, thereby ensuring reliable inventory management and global distribution.

Their comprehensive product portfolio encompasses essential diagnostic markers, such as FR, PCR, CK-MB, HIV/HIV-P24, HBV, and ToRCH, facilitating diverse applications across clinical biochemistry, CLIA, ELISA, and POCT arenas.

Commitment to Innovation



With 25 years of experience within the IVD industry, more than 1,400 patent applications, and partnerships spanning over 70 countries and regions, Fapon continues to drive diagnostic innovation through global collaboration. Their integrated technological capabilities, robust product portfolio, and localization-focused services underscore Fapon's commitment to advancing diagnostic development and strengthening local IVD manufacturing.

Visitors to MEDICA 2026 are encouraged to meet Fapon's team in Hall 3, Stand D95, to explore collaboration opportunities and learn more about their IVD solutions and services.

About Fapon



Fapon is at the forefront of transforming the diagnostics and therapeutics landscape by redefining R&D processes with a pioneering model that integrates artificial intelligence with a closed-loop cycle of both dry and wet experiments. This innovative approach significantly accelerates the discovery and translation of new biomarkers and therapeutic targets, establishing a cohesive business structure that merges AI-driven innovations with comprehensive diagnostic solutions and novel therapies. Fapon's offerings span the entire health management spectrum, expediting the development of precision medicine.

To stay updated, follow Fapon on LinkedIn (Fapon) or visit their website at https://en.faponbiotech.com/. For meeting arrangements, contact [email protected].

Topics Health)

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.